Growth Hormone
Growth Hormone Release Studies
Quantity
Ships from the United States with tracking · free shipping over $200
Certificates of analysis
Each certificate covers one production run, and reports on that batch alone. Open any of them to read the laboratory report exactly as the third-party lab issued it.
Authenticity
Scan the code on the label to pull up every published certificate for that compound — the same reports the third-party laboratory issued, batch by batch. Traceable from the laboratory that tested it to your bench.
Verify a batch →Independently tested
Purity is quantified by reverse-phase HPLC and identity confirmed by mass spectrometry, by an outside laboratory rather than in-house.
A certificate for your lot
The report that ships with your order describes the batch you received — not the product line, and not a representative sample.
COA-backed replacement
If material does not match the certificate issued for its lot, we replace it or refund it. Send us the lot number and we will trace it.
Tracked dispatch
Tracking is issued when the label is created, so the shipment is traceable from the moment it leaves us.
About this compound
C221H366N72O67S
Tesamorelin is a synthetic GHRH matching the full 44-residue human sequence, with a trans-3-hexenoyl group added at the N-terminus to resist enzymatic degradation. Unlike shorter GHRH fragments, it preserves the complete native sequence, and research examines growth hormone release and visceral adipose endpoints.
Full specification
How it works
The pathways Tesamorelin acts on, and what each one does. Signalling described from preclinical models.
Growth Hormone Secretagogue
A synthetic GHRH matching the full 44-residue human sequence, with a trans-3-hexenoyl group at the N-terminus to resist degradation. Unlike shorter fragments it preserves the complete native sequence.
Visceral Adipose Reduction
Visceral adipose tissue is the endpoint with the largest clinical dataset behind this compound, and the one that distinguishes it from other GHRH analogues in the literature.
Cognitive & Brain Research
A smaller body of work examines cognitive endpoints on the basis that growth hormone signalling reaches the central nervous system. Findings here are preliminary relative to the adipose data.
Uses & applications
The main areas under study, and the study-reported figures behind them.
Visceral adipose tissue carries the largest clinical dataset for this compound and distinguishes it from other GHRH analogues.
Falutz et al. 2010
Cognitive and imaging endpoints are examined on the basis that growth hormone signalling reaches the central nervous system.
Baker et al. 2019
IGF-1 is measured as the downstream marker of release, as with every compound acting upstream of the pituitary.
Stanley et al. 2011
Lipid profiles are tracked alongside body composition, since the two move together in this literature.
Falutz et al. 2014
What the published work measures
The endpoints reported across the literature for this compound. The figures belong to the individual papers, not to us.
Molecular structure
The verified reference values for this compound.
No 3D structure published
This compound is a long, flexible chain. Any single three-dimensional arrangement would be one of an enormous number it can adopt, so we do not show one. The sequence and the reference values beside this are the reliable description.
C221H366N72O67S
Third-party verified
Every batch of Tesamorelin is sent to an accredited independent laboratory before it ships. Here is what we screen for.
Quantifies purity and reports it on the lot certificate
Verifies the exact molecular identity
Lead, arsenic, cadmium & mercury
Bacterial endotoxin levels
No microbial contamination
Actual peptide mass per vial verified
FAQ
Tesamorelin is a synthetic GHRH matching the full 44-residue human sequence, with a trans-3-hexenoyl group added at the N-terminus to resist enzymatic degradation. Unlike shorter GHRH fragments, it preserves the complete native sequence, and research examines growth hormone release and visceral adipose endpoints.
Published research on Tesamorelin concentrates on Visceral Fat & Body Composition, Brain Structure & Function, GH/IGF-1 Axis and Lipid & Cardiovascular Markers. Each of those areas is summarised further up this page with the citation it comes from, and the full reference list — 4 indexed publications — sits at the bottom. Study designs and concentrations vary considerably between publications, so the primary sources are worth reading directly.
The literature describes Tesamorelin acting across Growth Hormone Secretagogue, Visceral Adipose Reduction and Cognitive & Brain Research, reported respectively as GHRH-R Agonism, Lipolysis and Neuroprotection. Those pathways are drawn from preclinical models rather than clinical work, and they describe what has been observed rather than a settled mechanism — the individual pathway cards above cite what each one is based on.
Tesamorelin has a molecular formula of C221H366N72O67S, an average mass of 5135.89 g/mol and the sequence Modified GHRH(1-44) analog (44 amino acids). It is indexed under CAS 218949-48-5. It ships as lyophilized powder. Those are nominal reference values for the parent compound. The identity of the specific material you receive is confirmed by mass spectrometry and reported on that lot's certificate.
Store the sealed vial at -20°C, protected from light and moisture, and let it reach room temperature before opening so condensation does not form on cold powder. Tesamorelin is water-soluble; reconstitute by directing the diluent down the vial wall rather than onto the powder, then swirl to dissolve rather than shaking. Keep reconstituted solution refrigerated and avoid repeated freeze-thaw cycles — solutions are far less stable than lyophilized powder.
No. Tesamorelin is supplied strictly for in-vitro laboratory research and development. It is not a drug, food, supplement or cosmetic, it has not been evaluated by the FDA, and it is not intended for human or animal consumption, ingestion, injection or any in-vivo use. Ordering confirms you are a qualified researcher or institution purchasing on that basis.
Cited sources
Independent published research indexed from PubMed and peer-reviewed journals — not Routine Peptides claims.
For research use only
Not for human or veterinary use. For in-vitro laboratory research only. These statements have not been evaluated by the FDA; this product is not intended to diagnose, treat, cure, or prevent any disease. Sold exclusively to qualified researchers and institutions.
Before you order
Every production run is analyzed by an independent laboratory, and the certificate for your lot travels with the order — not a catalog-wide document, and not a summary written by us.
